Aurinia Pharmaceuticals Inc (AUPH)
5.03
-0.06
(-1.18%)
USD |
NASDAQ |
Apr 24, 16:00
5.03
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Market Cap: 727.43M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 735.38M |
| April 22, 2024 | 730.32M |
| April 19, 2024 | 721.64M |
| April 18, 2024 | 695.61M |
| April 17, 2024 | 710.07M |
| April 16, 2024 | 723.09M |
| April 15, 2024 | 728.87M |
| April 12, 2024 | 737.55M |
| April 11, 2024 | 734.66M |
| April 10, 2024 | 721.64M |
| April 09, 2024 | 739.00M |
| April 08, 2024 | 720.20M |
| April 05, 2024 | 730.32M |
| April 04, 2024 | 736.10M |
| April 03, 2024 | 749.12M |
| April 02, 2024 | 734.66M |
| April 01, 2024 | 780.94M |
| March 28, 2024 | 724.54M |
| March 27, 2024 | 723.09M |
| March 26, 2024 | 712.97M |
| March 25, 2024 | 721.64M |
| March 22, 2024 | 718.75M |
| March 21, 2024 | 724.54M |
| March 20, 2024 | 743.34M |
| March 19, 2024 | 749.12M |
| Date | Value |
|---|---|
| March 18, 2024 | 736.10M |
| March 15, 2024 | 747.67M |
| March 14, 2024 | 736.10M |
| March 13, 2024 | 759.24M |
| March 12, 2024 | 752.01M |
| March 11, 2024 | 776.60M |
| March 08, 2024 | 785.27M |
| March 07, 2024 | 788.17M |
| March 06, 2024 | 798.29M |
| March 05, 2024 | 809.86M |
| March 04, 2024 | 833.00M |
| March 01, 2024 | 835.89M |
| February 29, 2024 | 827.21M |
| February 28, 2024 | 844.57M |
| February 27, 2024 | 870.60M |
| February 26, 2024 | 867.71M |
| February 23, 2024 | 860.48M |
| February 22, 2024 | 867.71M |
| February 21, 2024 | 830.11M |
| February 20, 2024 | 808.41M |
| February 16, 2024 | 846.01M |
| February 15, 2024 | 870.60M |
| February 14, 2024 | 1.153B |
| February 13, 2024 | 1.119B |
| February 12, 2024 | 1.197B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
365.83M
Minimum
Oct 14 2019
4.286B
Maximum
Oct 29 2021
1.510B
Average
1.558B
Median
Jul 24 2023
Market Cap Benchmarks
| Lexaria Bioscience Corp | 28.61M |
| Acasti Pharma Inc | 28.20M |
| Edesa Biotech Inc | 13.70M |
| Xenon Pharmaceuticals Inc | 2.983B |
| ESSA Pharma Inc | 285.78M |
Market Cap Related Metrics
| PS Ratio | 4.098 |
| Price to Book Value | 1.925 |
| Price | 5.03 |
| Earnings Yield | -10.54% |